Estados financieros detallados de BeyondSpring Inc. (BYSI): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.71, BYSI presenta beneficios negativos (P/E no significativo) y un ROE del 19.96%. La capitalización bursátil es de $29M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | $180000 | $1.4M | $1.4M | 0 | 0 | 0 |
| Coste de Ventas | $18000 | $32000 | $48000 | $77000 | 0 | 0 | 0 | $302000 | 0 | $87000 |
| Beneficio Bruto | -$18000 | -$32000 | -$48000 | -$77000 | $180000 | $1.4M | $1.4M | -$302000 | 0 | -$87000 |
| I+D | $10.4M | $88.9M | $51.6M | $31.3M | $41.8M | $36.9M | $25.6M | $7.3M | $2.6M | $4.4M |
| Generales y Administrativos | $1.9M | $9.1M | $5.9M | $8.9M | $22.6M | $30.7M | $13.0M | $7.5M | $6.1M | $4.6M |
| Gastos Operativos | $12.4M | $98.0M | $57.5M | $40.2M | $64.4M | $67.6M | $38.6M | $14.8M | $8.8M | $8.9M |
| Beneficio Operativo | -$12.4M | -$98.0M | -$57.5M | -$40.3M | -$64.2M | -$66.2M | -$37.2M | -$15.1M | -$8.8M | -$8.9M |
| EBITDA | -$12.3M | -$97.9M | -$57.5M | -$40.0M | -$63.7M | -$64.5M | -$35.0M | -$13.6M | -$8.5M | -$8.5M |
| Gastos por Intereses | $177000 | 0 | 0 | $206000 | $85000 | $87000 | $17000 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$12.5M | -$96.4M | -$57.5M | -$40.3M | -$63.8M | -$64.6M | -$36.1M | -$13.9M | -$8.8M | -$8.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | $3.6M | $163000 | $92000 | $96000 | $90000 |
| Beneficio Neto | -$12.0M | -$91.8M | -$54.9M | -$38.1M | -$61.0M | -$64.2M | -$33.3M | -$21.0M | -$11.1M | -$8.0M |
| BPA | $-0.75 | $-4.40 | $-2.42 | $-1.55 | $-2.04 | $-1.64 | $-0.85 | $-0.54 | $-0.28 | $-0.20 |
| BPA Diluido | $-0.71 | $-4.40 | $-2.42 | $-1.55 | $-2.04 | $-1.64 | $-0.85 | $-0.54 | $-0.28 | $-0.20 |
| Acciones en Circulación (Diluidas) | $16.9M | $20.9M | $22.7M | $24.6M | $30.0M | $39.0M | $39.1M | $39.0M | $39.7M | $40.4M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $11.7M | $27.5M | $3.9M | $35.9M | $109.5M | $41.6M | $34.4M | $15.3M | $2.9M | $7.8M |
| Inversiones a Corto | 0 | $3.1M | 0 | 0 | 0 | $30.7M | $2.9M | 0 | 0 | $4.8M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | $799000 | 0 | $1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $14.7M | $32.3M | $5.9M | $40.9M | $113.4M | $75.1M | $38.5M | $18.4M | $28.6M | $20.9M |
| Inmovilizado Material | $80000 | $123000 | $282000 | $2.7M | $2.4M | $5.0M | $7.4M | $1.0M | $752000 | $471000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $14.9M | $32.8M | $7.1M | $44.6M | $117.0M | $81.6M | $46.2M | $24.8M | $34.3M | $25.9M |
| Cuentas por Pagar | $444000 | $3.4M | $9.6M | $2.5M | $2.2M | $1.7M | $1.1M | $561000 | $295000 | $363000 |
| Deuda a Corto | $210000 | 0 | 0 | $29000 | 0 | $1.6M | 0 | $258000 | 0 | 0 |
| Pasivos Corrientes | $2.6M | $4.8M | $16.4M | $10.1M | $13.8M | $15.2M | $7.4M | $8.0M | $11.0M | $13.6M |
| Deuda a Largo | 0 | 0 | 0 | $1.4M | $2.2M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.6M | $4.8M | $16.4M | $13.4M | $25.2M | $60.7M | $49.2M | $48.3M | $48.6M | $49.9M |
| Reservas | -$32.1M | -$123.9M | -$178.8M | -$216.8M | -$277.8M | -$342.0M | -$375.3M | -$396.3M | -$407.4M | -$408.4M |
| Patrimonio Neto | $12.2M | $27.1M | -$7.8M | $30.3M | $88.3M | $26.7M | -$6.0M | -$26.8M | -$32.9M | -$32.2M |
| Deuda Total | $210000 | 0 | 0 | $3.9M | $4.3M | $3.6M | $5.0M | $847000 | $589000 | $320000 |
| Deuda Neta | -$11.5M | -$30.6M | -$3.9M | -$32.0M | -$105.2M | -$68.8M | -$32.3M | -$14.5M | -$2.3M | -$12.2M |
| Capital Circulante | $12.1M | $27.6M | -$10.6M | $30.8M | $99.6M | $60.0M | $31.2M | $10.5M | $17.6M | $7.3M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +650.6% | +0.0% | -100.0% | |||||||
| Crecimiento Beneficio Neto (anual) | -664.1% | +40.2% | +30.6% | -60.1% | -5.3% | +48.1% | +36.8% | +47.1% | +28.1% | |
| Crecimiento BPA (anual) | -486.7% | +45.0% | +36.0% | -31.6% | +19.6% | +48.2% | +36.5% | +48.1% | +28.6% | |
| Cambio en Acciones (anual) | +23.6% | +8.6% | +8.7% | +21.7% | +30.1% | +0.2% | -0.2% | +1.9% | +1.7% | |
| Margen Bruto | 100.0% | 100.0% | 100.0% | |||||||
| Margen Operativo | -35672.8% | -4903.0% | -2756.4% | |||||||
| Margen EBITDA | -35366.1% | -4773.5% | -2587.4% | |||||||
| Margen Neto | -33873.9% | -4750.5% | -2463.3% | |||||||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -5.5% | -0.5% | -0.7% | -1.1% | -1.0% |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 19.96% |
| Rentabilidad sobre capital invertido | -1429.62% |
| Rentabilidad sobre activos | -45.77% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | -0.00 |
| Ratio corriente | 0.70 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -22.40 | -6.59 | -7.75 | -10.00 | -5.98 | -2.76 | -2.21 | -1.67 | -5.82 | -8.15 |
| P/VC | 22.24 | 22.35 | -54.72 | 12.62 | 4.14 | 6.62 | -12.29 | -1.31 | -1.97 | -2.05 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 2032.27 | 130.85 | 54.40 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | -35672.8% | -4903.0% | -2756.4% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | -33873.9% | -4750.5% | -2463.3% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ALXO · ATYR · BMEA · CAMP · DTIL · GUTS · HYFT
Explorar sector: Healthcare · Biotechnology
Más secciones de BYSI: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones